Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMP | P19971 | 15/20 | 0.66 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.43 |
| ▸ | IMPDH2 | P12268 | 2/20 | 0.43 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.43 |
| ▸ | HINT1 | P49773 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22577504 | 0.90 | TYMP (0.54) | TYMPADORA1IMPDH2IMPDH1 | |
| SCHEMBL22577502 | 0.83 | TYMP (0.46) | TYMPIMPDH2IMPDH1 | |
| SCHEMBL6420722 | 0.81 | TYMP (0.79) | TYMPADORA1HINT1 | |
| SCHEMBL22577600 | 0.81 | TYMP (0.44) | TYMP | |
| SCHEMBL22577529 | 0.80 | TYMP (0.56) | TYMPADORA1 | |
| SCHEMBL20691415 | 0.80 | TYMP (1.00) | TYMPADORA1 | |
| SCHEMBL20214677 | 0.80 | TYMP (0.77) | TYMPADORA1IMPDH2IMPDH1 | |
| SCHEMBL21586639 | 0.80 | TYMP (0.66) | TYMPADORA1 | |
| SCHEMBL22577537 | 0.80 | TYMP (0.60) | TYMPADORA1 | |
| SCHEMBL22879159 | 0.79 | TYMP (0.78) | TYMPADORA1IMPDH2IMPDH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210206796-A1 | CYCLIC DI-NUCLEOTIDE COMPOUNDS AS STING AGONISTS | MERCK SHARP & DOHME CORP. (US) | 2021-07-08 | — | — | US | disclosed |
| EP-3727401-A1 | CYCLIC DI-NUCLEOTIDE COMPOUNDS AS STING AGONISTS | MERCK SHARP & DOHME CORP. (US) | 2020-10-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210206796-A1 | CYCLIC DI-NUCLEOTIDE COMPOUNDS AS STING AGONISTS | STING1, CGAS, IFNAR1 | TYMP 2186/4885ADORA1 34/4885IMPDH2 1168/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.